Transforming growth factor b and cell cycle regulation, Cancer Res, vol.55, pp.1452-1457, 1995. ,
Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth, Oncogene, vol.23, issue.41, pp.6986-6990, 2004. ,
DOI : 10.1038/sj.onc.1207859
Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7, 12-dimethylbenz-[a]-anthracene, Cancer Res, vol.57, pp.5564-5570, 1997. ,
Altered expression of transforming growth factor-? ligands and receptors in primary and recurrent ovarian carcinoma, Cancer, vol.56, issue.3, pp.658-668, 1999. ,
DOI : 10.1002/(SICI)1097-0142(19990201)85:3<658::AID-CNCR16>3.0.CO;2-M
Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast., International Journal of Oncology, vol.15, pp.187-194, 1999. ,
DOI : 10.3892/ijo.15.1.187
Transforming growth factor-b type I receptor kinase mutant associated with metastatic breast cancer, Cancer Res, vol.58, pp.4805-4810, 1998. ,
Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node matastases of human mammary carcinoma, Am J Pathol, vol.143, pp.381-389, 1993. ,
TGF alpha and TGF beta expression in mammary carcinoma, The Journal of Pathology, vol.5, issue.1, pp.15-22, 1993. ,
DOI : 10.1002/path.1711700104
Urokinase plasminogen activator: a prognostic marker in breast cancer including patients with axillary node-negative disease, Clin Chem, vol.44, pp.1177-1183, 1998. ,
Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast cancer tumor cytosol, Cancer Res, vol.49, pp.5823-5828, 1989. ,
Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy, Cancer Res, vol.61, pp.1421-1425, 2001. ,
Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human oesophageal squamous cell carcinoma, Int J Cancer, vol.20, pp.161-166, 2003. ,
Prognostic significance of TGF beta 1 and TGF beta 3 in human breast carcinoma, Anticancer Res, vol.20, pp.4413-4418, 2000. ,
Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas, Histopathology, vol.21, issue.2, pp.168-177, 2000. ,
DOI : 10.1126/science.282.5397.2270
Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer, Cancer Res, vol.52, pp.6949-6952, 1992. ,
Mutational inactivation of transforming growth factor b receptor type II in microsatellite stable cancer colon, Cancer Res, vol.59, pp.320-324, 1999. ,
Elevated plasma levels of TGF-??1 in patients with invasive prostate cancer, Nature Medicine, vol.87, issue.4, pp.282-284, 1995. ,
DOI : 10.1210/me.6.1.15
Elevated plasma levels of transforming growth factor-??1 (TGF-??1) in patients with advanced breast cancer: association with disease progression, European Journal of Cancer, vol.39, issue.4, pp.454-461, 2003. ,
DOI : 10.1016/S0959-8049(02)00502-6
Downregulation of activin, activin receptors, and smads in high-grade breast cancer, Cancer Res, vol.63, pp.3783-3790, 2003. ,
Targeting expression of a transforming growth factor b1 transgene to the pregnant mammary gland inhibits alveolar development and lactation, EMBO J, vol.12, pp.1835-1845, 1993. ,
Transforming growth factor beta related to extent of tumo angiogenesis but not apoptosis or proliferation in breast carcinoma, Breast Cancer, vol.25, pp.29-36, 1999. ,
Evidence that transforming growth factor-?? is a hormonally regulated negative growth factor in human breast cancer cells, Cell, vol.48, issue.3, pp.417-428, 1987. ,
DOI : 10.1016/0092-8674(87)90193-0
Elevated Plasma Transforming Growth Factor-??1 Levels in Breast Cancer Patients Decrease After Surgical Removal of the Tumor, Annals of Surgery, vol.222, issue.2, pp.155-162, 1995. ,
DOI : 10.1097/00000658-199508000-00007
Transforming growth factor beta 1 serum levels in patients with preinvasive and invasive lesions of the breast, The International Journal of Biological Markers, vol.19, issue.3, pp.236-239, 2004. ,
DOI : 10.5301/JBM.2008.2143
REGULATION OF IMMUNE RESPONSES BY TGF-??, Annual Review of Immunology, vol.16, issue.1, pp.137-161, 1998. ,
DOI : 10.1146/annurev.immunol.16.1.137
Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients, JNCI Journal of the National Cancer Institute, vol.94, issue.2, pp.116-128, 2002. ,
DOI : 10.1093/jnci/94.2.116
Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer, Oncogene, vol.22, issue.31, pp.4889-4897, 2003. ,
DOI : 10.1038/sj.onc.1206806
Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions, Int J Cancer, vol.20, pp.160-168, 1999. ,
The prognostic significance of transforming growth factors in human breast cancer, British Journal of Cancer, vol.67, issue.6, pp.1408-1412, 1993. ,
DOI : 10.1038/bjc.1993.261
TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells., Genes & Development, vol.10, issue.19, pp.2462-2477, 1996. ,
DOI : 10.1101/gad.10.19.2462
Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis, Proceedings of the National Academy of Sciences, vol.196, issue.2, pp.2626-2631, 2000. ,
DOI : 10.1002/aja.1001960207
TGF-b-induced apoptosis is mediated by the adaptor protein DAXX that facilitates JNK activation, Nat Cell Biol, vol.13, pp.708-714, 2001. ,
Inhibition of transforming growth factor-beta and matrix metalloproteinases by estrogen and prolactin in breast cancer cells, Cancer Letters, vol.206, issue.1, pp.63-68, 2004. ,
DOI : 10.1016/j.canlet.2003.10.019
A subset of metastasis human colon cancers expresses elevated levels of transforming growth factor beta1, Cancer Epidemiol Biomarkers Prev, vol.7, pp.497-504, 1998. ,
Mammary tumor suppression by transforming growth factor b1 transgene expression, Proc Natl Acad Sci, vol.92, pp.4254-4258, 1995. ,
The transforming growth factor-bs In Peptide Growth Factors and their Receptors, Part I Sprone MB Steroid receptor distribution in 47892 breast cancers. A collaborative study of 7 European laboratories, Eur J Cancer, vol.31, pp.419-472, 1990. ,
Prognostic of DNA-synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1-T2, N0-N1, M0 breast cancers: A retrospective multicenter study, International Journal of Cancer, vol.75, issue.6, pp.860-868, 2000. ,
DOI : 10.1002/1097-0215(20000915)87:6<860::AID-IJC16>3.0.CO;2-Y
Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer, Clinical Cancer Research, vol.10, issue.7, pp.2289-2298, 2004. ,
DOI : 10.1158/1078-0432.CCR-03-0360
Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis, Proceedings of the National Academy of Sciences, vol.7, issue.1, pp.9624-9629, 2000. ,
DOI : 10.1016/S1359-6101(99)00012-X
Association of Pre- and Postoperative Plasma Levels of Transforming Growth Factor ??1 and Interleukin 6 and Its Soluble Receptor with Prostate Cancer Progression, Clinical Cancer Research, vol.10, issue.6, pp.1992-1999, 2004. ,
DOI : 10.1158/1078-0432.CCR-0768-03
Apoptotic cell death and tissue remodelling during mouse mammary gland involution, Development, vol.115, pp.49-58, 1992. ,
High levels of transforming growth factor beta 1 in patients with colorectal cancer: Association with disease progression, Gastroenterology, vol.110, issue.2, pp.375-382, 1996. ,
DOI : 10.1053/gast.1996.v110.pm8566583
Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer, Clin Cancer Res, vol.1, pp.129-136, 1995. ,
TGF-b signaling in mammary gland development and tumorigenesis, Journal of Mammary Gland Biology and Neoplasia, vol.6, issue.1, pp.67-82, 2000. ,
DOI : 10.1023/A:1009568532177
Relationship of transforming growth factor ??1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma, British Journal of Cancer, vol.69, issue.6, pp.1160-1165, 1994. ,
DOI : 10.1038/bjc.1994.228
Analysis of specific gene mutations in the transforming growth factor-b signal transduction pathway in human ovarian cancer, Cancer Res, vol.60, pp.4507-4512, 2000. ,
Multiple transforming growth factor-beta-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells, J Biol Chem, vol.266, pp.1092-1100, 1991. ,
Alterations of smad signaling in human breast carcinoma are associated with poor outcome. A tissue microarray study, Cancer Res, vol.62, pp.497-505, 2002. ,